logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Otitis Externa

    Medications for Otitis Externa

    FiltersReset Filters
    5 results

    • cetraxal

      (Ciprofloxacin)
      Wraser Llc
      Usage: CETRAXAL is a quinolone antimicrobial indicated for treating acute otitis externa caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus.

    • ciprofloxacin and dexamethasone

      (Ciprofloxacin and dexamethasone)
      Sun Pharmaceutical Industries, Inc.
      Usage: Ciprofloxacin and dexamethasone otic suspension is indicated for treating acute otitis externa in pediatric (6 months and older), adult, and elderly patients due to infections from susceptible strains of Staphylococcus aureus and Pseudomonas aeruginosa.

    • fluocinolone acetonide

      (Fluocinolone Acetonide)
      Amneal Pharmaceuticals LLC
      Usage: Fluocinolone Acetonide Oil 0.01% is indicated for treating chronic eczematous external otitis in adults and pediatric patients aged 2 years and older.

    • ofloxacin

      (Ofloxacin)
      Somerset Therapeutics, LLC
      Usage: Ofloxacin otic solution 0.3% is indicated for treating otitis externa in patients 6 months and older, chronic suppurative otitis media in patients 12 years and older with perforated tympanic membranes, and acute otitis media in pediatric patients with tympanostomy tubes, caused by specific susceptible bacteria.

    • ofloxacin

      (Ofloxacin)
      Rising Pharmaceuticals, Inc.
      Usage: Ofloxacin otic solution 0.3% is indicated for treating Otitis Externa in patients 6 months and older and Chronic Suppurative Otitis Media in those 12 years and older. It is also used for Acute Otitis Media in pediatric patients 1 year and older with tympanostomy tubes, targeting specific bacteria.